Top compounds associated with response to IPO4

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	tivantinib	CTRPv2	pan-cancer	AAC	0.093	0.04
mRNA	ML083	CTRPv2	pan-cancer	AAC	-0.078	0.05
mRNA	compound 1B	CTRPv2	pan-cancer	AAC	-0.077	0.05
mRNA	Bortezomib	CTRPv2	pan-cancer	AAC	-0.069	0.05
mRNA	Sunitinib	CTRPv2	pan-cancer	AAC	-0.068	0.05
mRNA	ceranib-2	CTRPv2	pan-cancer	AAC	0.064	0.06
mRNA	navitoclax:pluripotin (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.07	0.06
mRNA	MLN2238	CTRPv2	pan-cancer	AAC	-0.066	0.06
mRNA	austocystin d	CTRPv2	pan-cancer	AAC	0.071	0.06
mRNA	erlotinib:PLX-4032 (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.072	0.06

Download CSV